439 related articles for article (PubMed ID: 31117041)
1. NCCN Guidelines Updates: Pancreatic Cancer.
Tempero MA
J Natl Compr Canc Netw; 2019 May; 17(5.5):603-605. PubMed ID: 31117041
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.
Tempero MA; Arnoletti JP; Behrman SW; Ben-Josef E; Benson AB; Casper ES; Cohen SJ; Czito B; Ellenhorn JD; Hawkins WG; Herman J; Hoffman JP; Ko A; Komanduri S; Koong A; Ma WW; Malafa MP; Merchant NB; Mulvihill SJ; Muscarella P; Nakakura EK; Obando J; Pitman MB; Sasson AR; Tally A; Thayer SP; Whiting S; Wolff RA; Wolpin BM; Freedman-Cass DA; Shead DA;
J Natl Compr Canc Netw; 2012 Jun; 10(6):703-13. PubMed ID: 22679115
[TBL] [Abstract][Full Text] [Related]
3. CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.
Wagner M; Antunes C; Pietrasz D; Cassinotto C; Zappa M; Sa Cunha A; Lucidarme O; Bachet JB
Eur Radiol; 2017 Jul; 27(7):3104-3116. PubMed ID: 27896469
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Tempero MA; Malafa MP; Al-Hawary M; Asbun H; Bain A; Behrman SW; Benson AB; Binder E; Cardin DB; Cha C; Chiorean EG; Chung V; Czito B; Dillhoff M; Dotan E; Ferrone CR; Hardacre J; Hawkins WG; Herman J; Ko AH; Komanduri S; Koong A; LoConte N; Lowy AM; Moravek C; Nakakura EK; O'Reilly EM; Obando J; Reddy S; Scaife C; Thayer S; Weekes CD; Wolff RA; Wolpin BM; Burns J; Darlow S
J Natl Compr Canc Netw; 2017 Aug; 15(8):1028-1061. PubMed ID: 28784865
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic Adenocarcinoma, Version 1.2019.
Tempero MA; Malafa MP; Chiorean EG; Czito B; Scaife C; Narang AK; Fountzilas C; Wolpin BM; Al-Hawary M; Asbun H; Behrman SW; Benson AB; Binder E; Cardin DB; Cha C; Chung V; Dillhoff M; Dotan E; Ferrone CR; Fisher G; Hardacre J; Hawkins WG; Ko AH; LoConte N; Lowy AM; Moravek C; Nakakura EK; O'Reilly EM; Obando J; Reddy S; Thayer S; Wolff RA; Burns JL; Zuccarino-Catania G
J Natl Compr Canc Netw; 2019 Mar; 17(3):202-210. PubMed ID: 30865919
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC).
Neuzillet C; Gaujoux S; Williet N; Bachet JB; Bauguion L; Colson Durand L; Conroy T; Dahan L; Gilabert M; Huguet F; Marthey L; Meilleroux J; de Mestier L; Napoléon B; Portales F; Sa Cunha A; Schwarz L; Taieb J; Chibaudel B; Bouché O; Hammel P; ; ; ; ; ; ; ; ; ;
Dig Liver Dis; 2018 Dec; 50(12):1257-1271. PubMed ID: 30219670
[TBL] [Abstract][Full Text] [Related]
7. Dramatic response of FOLFIRINOX regimen in a collision pancreatic adenocarcinoma patient with a germline BRCA2 mutation: a case report.
Shimmura H; Kuramochi H; Jibiki N; Katagiri S; Nishino T; Araida T
Jpn J Clin Oncol; 2019 Dec; 49(11):1049-1054. PubMed ID: 31612916
[TBL] [Abstract][Full Text] [Related]
8. Pathologic Response to Primary Systemic Therapy With FOLFIRINOX in Patients With Resectable Pancreatic Cancer.
Polish A; Joseph NE; Marsh RW
Am J Clin Oncol; 2019 Oct; 42(10):761-766. PubMed ID: 31569128
[TBL] [Abstract][Full Text] [Related]
9. Clinical Management: Metastatic Disease.
Ko AH
Cancer J; 2017; 23(6):355-361. PubMed ID: 29189332
[TBL] [Abstract][Full Text] [Related]
10. Clinical overview: adjuvant therapy of gastrointestinal cancer.
Macdonald JS
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S4-11. PubMed ID: 15309508
[TBL] [Abstract][Full Text] [Related]
11. Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Brus C; Saif MW
JOP; 2010 Jul; 11(4):321-3. PubMed ID: 20601802
[TBL] [Abstract][Full Text] [Related]
12. Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX.
Sehdev A; Gbolahan O; Hancock BA; Stanley M; Shahda S; Wan J; Wu HH; Radovich M; O'Neil BH
Clin Cancer Res; 2018 Dec; 24(24):6204-6211. PubMed ID: 30131383
[TBL] [Abstract][Full Text] [Related]
13. [Readout from NCCN clinical practice guideline in pancreatic adenocarcinoma and discussion on several related issues].
Yang YM; Xie XH; Gao HQ
Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(11):801-3. PubMed ID: 19961005
[No Abstract] [Full Text] [Related]
14. NCCN Guidelines Updates: Management of Metastatic Colorectal Cancer.
Messersmith WA
J Natl Compr Canc Netw; 2019 May; 17(5.5):599-601. PubMed ID: 31117039
[TBL] [Abstract][Full Text] [Related]
15. Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Fleeman N; Abdulla A; Bagust A; Beale S; Richardson M; Stainthorpe A; Boland A; Kotas E; McEntee J; Palmer D
Pharmacoeconomics; 2018 Mar; 36(3):289-299. PubMed ID: 29178025
[TBL] [Abstract][Full Text] [Related]
16. Best practices for the treatment of metastatic pancreatic adenocarcinoma: the therapeutic landscape in 2017.
Cinar P; Ko AH
Chin Clin Oncol; 2017 Jun; 6(3):29. PubMed ID: 28705006
[TBL] [Abstract][Full Text] [Related]
17. Modified-FOLFIRINOX combined with deep regional hyperthermia in pancreatic cancer: a retrospective study in Chinese patients.
He M; Sun J; Zhao D; He H; Wang B; Xu L; Shang Y; Ren S; Zhang Y; Wu T
Int J Hyperthermia; 2019; 36(1):394-402. PubMed ID: 30917701
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of Modified FOLFIRINOX Regimens for Patients With Metastatic Pancreatic Cancer.
Usón Junior PLS; Rother ET; Maluf FC; Bugano DDG
Clin Colorectal Cancer; 2018 Sep; 17(3):187-197. PubMed ID: 29615310
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary management of pancreatic cancer.
Kumar R; Herman JM; Wolfgang CL; Zheng L
Surg Oncol Clin N Am; 2013 Apr; 22(2):265-87. PubMed ID: 23453334
[TBL] [Abstract][Full Text] [Related]
20. SEOM Clinical Guideline for the treatment of pancreatic cancer (2016).
Vera R; Dotor E; Feliu J; González E; Laquente B; Macarulla T; Martínez E; Maurel J; Salgado M; Manzano JL
Clin Transl Oncol; 2016 Dec; 18(12):1172-1178. PubMed ID: 27896637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]